Effect of Testosterone on Proliferation Markers and Apoptosis in Breasts of Ovariectomized Rats
收藏DataCite Commons2020-08-26 更新2024-07-28 收录
下载链接:
https://scielo.figshare.com/articles/Effect_of_Testosterone_on_Proliferation_Markers_and_Apoptosis_in_Breasts_of_Ovariectomized_Rats/11804376
下载链接
链接失效反馈官方服务:
资源简介:
Abstract Objective To investigate the action of testosterone (T), isolated or associated with estradiol benzoate (EB), on the proliferation markers and apoptosis of breasts of ovariectomized rats. Methods A total of 48 castrated female Wistar rats were divided into 6 groups, and each of them were submitted to one of the following treatments for 5 weeks: 1) control; 2) EB 50 mcg/day + T 50 mcg/day; 3) T 50mcg/day; 4) EB 50 mcg +T 300 mcg/day; 5) T 300 mcg/day; and 6) EB 50 mcg/day. After the treatment, the mammary tissue was submitted to a histological analysis and immunoexpression evaluation of proliferation markers (proliferating cell nuclear antigen, PCNA) and apoptosis (caspase-3). Results There was a statistically significant difference among the groups regarding microcalcifications and secretory activity, with higher prevalence in the groups treated with EB. There was no difference among the groups regarding atrophy, but a higher prevalence of atrophy was found in the groups that received T versus those that received EB +T. There was a difference among the groups regarding the PCNA (p = 0.028), with higher expression in the group submitted to EB +T 300 mcg/day. Regarding caspase-3, there was no difference among the groups; however, in the group submitted to EB +T 300 mcg/day, the expression was higher than in the isolated T group. Conclusion Isolated T did not have a proliferative effect on the mammary tissue, contrary to EB. Testosterone in combination with EB may or may not decrease the proliferation, depending on the dose of T.
摘要 目的:探讨单独或联合苯甲酸雌二醇(Estradiol Benzoate, EB)的睾酮(Testosterone, T)对去卵巢大鼠乳腺组织增殖标志物及细胞凋亡的影响。方法:共纳入48只去势雌性Wistar大鼠,随机分为6组,每组分别接受以下一种处理方案,持续5周:1)对照组;2)苯甲酸雌二醇(EB)50 μg/天+睾酮(T)50 μg/天;3)睾酮(T)50 μg/天;4)苯甲酸雌二醇(EB)50 μg+睾酮(T)300 μg/天;5)睾酮(T)300 μg/天;6)苯甲酸雌二醇(EB)50 μg/天。处理结束后,对乳腺组织进行组织学分析,并检测增殖标志物(增殖细胞核抗原(proliferating cell nuclear antigen, PCNA))与细胞凋亡(半胱氨酸天冬氨酸蛋白酶3(caspase-3))的免疫表达水平。结果:各组在乳腺微钙化与分泌活性方面存在统计学显著性差异,苯甲酸雌二醇(EB)处理组的微钙化与分泌活性发生率更高。各组在乳腺萎缩方面无显著差异,但接受睾酮(T)处理的大鼠组萎缩发生率高于联合使用苯甲酸雌二醇与睾酮(EB+T)的组。各组的增殖细胞核抗原(PCNA)表达水平存在显著差异(p=0.028),其中苯甲酸雌二醇(EB)50 μg+睾酮(T)300 μg/天处理组的PCNA表达水平更高。关于半胱氨酸天冬氨酸蛋白酶3(caspase-3)的表达,各组总体无显著差异,但苯甲酸雌二醇(EB)50 μg+睾酮(T)300 μg/天处理组的表达水平高于单独使用睾酮(T)的组。结论:单独使用睾酮(T)对乳腺组织无增殖作用,与苯甲酸雌二醇(EB)的作用相反。睾酮与苯甲酸雌二醇联合使用时,是否会抑制乳腺组织增殖取决于睾酮的给药剂量。
提供机构:
SciELO journals
创建时间:
2020-02-05



